Technology | June 06, 2010

Biocompatible Gold Markers Track Tumors for IGRT

June 7, 2010 - One of the biggest challenges in image-guided treatments is tissue location. To help guide visibility, new biocompatible pure gold implanted markers are designed to identify the location of normal or diseased tissue for future treatments, including image-guided radiation therapy (IGRT).

The markers, FlexiMarc and FlexiCoil, used primarily for IGRT, are the first implanted fiducials designed with image projection and marker stability as the primary objectives. Unique node-based technology projects a non-biological image providing the best reference for accurate localization. Both the human eye and software programs can identify FlexiMarc and FlexiCoil.

FlexiMarc’s clearly definable nodes and endpoints project a non-biological image for better automated registration or point based localization. FlexiMarc is available in two or three node variations; nodes are fixed 10 mm apart, are 3 mm long and are available in 0.9 and 1.2 mm diameters.

FlexiCoil was designed with the same imaging advantages as FlexiMarc, but the nodes are placed inside a pure gold coil. FlexiCoil is constructed of a flexible pure gold coil, and is available in 10 and 20 mm lengths. 30 mm lengths will be available shortly. FlexiCoils are currently available with 0.9 and 1.2 mm diameters, and smaller diameter markers are in development. Nodes are placed at each end of the coil, making it simple to locate and determine the exact end of the line.

For more information: www.civco.com

Related Content

SpaceOAR Hydrogel Now Available in Japan
News | Patient Positioning Radiation Therapy | July 16, 2018
Augmenix K.K. announced that SpaceOAR hydrogel, a soft, implanted absorbable gel spacer is now available to all...
RaySearch Releases New Version of RayCare OIS
Technology | Oncology Information Management Systems (OIMS) | July 13, 2018
RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
Bruce Power Joins Forces With ITM to Supply Lutetium-177 for Cancer Therapy
News | Radiation Therapy | July 11, 2018
Canadian nuclear power company Bruce Power and German-based Isotope Technologies Garching (ITG) signed an agreement to...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
Northern Centre for Cancer Care (NCCC)

Northern Centre for Cancer Care (NCCC).

Sponsored Content | Case Study | Radiation Therapy | July 05, 2018
Established in 2009, Northern Centre for Cancer Care (NCCC) is the largest center of its kind in the north of England....
Feature | Proton Therapy | July 03, 2018 | By Jeff Zagoudis
The Alliance for Proton Therapy Access (APTA) released a national report in late May revealing the heavy emotional and...
Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Overlay Init